Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in October 2009
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
| BREATHTEK UBT FOR H-PYLORI | Otsuka America | urea, c-13 | 4,830,010 | Oct 27, 2009 |
| CEDAX | Sciele Pharma Inc | ceftibuten dihydrate | 4,634,697 | Oct 1, 2009 |
| COLGATE TOTAL | Colgate Palmolive | sodium fluoride; triclosan | 5,156,835 | Oct 20, 2009 |
| COVERA-HS | Gd Searle Llc | verapamil hydrochloride | 5,785,994 | Oct 22, 2009 |
| DOXIL | Ortho Biotech | doxorubicin hydrochloride | 5,013,556 | Oct 20, 2009 |
| DOXIL | Ortho Biotech | doxorubicin hydrochloride | 5,213,804 | Oct 20, 2009 |
| FLOMAX | Boehringer Ingelheim | tamsulosin hydrochloride | 4,703,063 | Oct 27, 2009 |
| INVEGA SUSTENNA | Johnson And Johnson | paliperidone palmitate | 5,254,556 | Oct 27, 2009 |
| MERETEK UBT KIT (W/ PRANACTIN) | Otsuka America | urea, c-13 | 4,830,010 | Oct 27, 2009 |
| PERMAX | Valeant Pharm Intl | pergolide mesylate | 5,114,948 | Oct 19, 2009 |
*Drugs may be covered by multiple patents
Courtesy of DrugPatentWatch.com
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.
![[Bloglines]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/bloglines.png)
![[del.icio.us]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/digg.png)
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)
